rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2008-4-23
|
pubmed:databankReference |
|
pubmed:abstractText |
Duloxetine and escitalopram were compared in an 8-month, randomized, double-blind, placebo-controlled trial in adult outpatients meeting DSM-IV criteria for major depressive disorder (MDD). The results regarding the primary objective of the study (onset of antidepressant action) have been previously published. The current paper focuses on the longer-term (8-month) comparisons of efficacy and safety between duloxetine and escitalopram.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1473-4877
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1303-18
|
pubmed:meshHeading |
pubmed-meshheading:17559729-Adolescent,
pubmed-meshheading:17559729-Adult,
pubmed-meshheading:17559729-Aged,
pubmed-meshheading:17559729-Algorithms,
pubmed-meshheading:17559729-Antidepressive Agents,
pubmed-meshheading:17559729-Citalopram,
pubmed-meshheading:17559729-Depressive Disorder, Major,
pubmed-meshheading:17559729-Dose-Response Relationship, Drug,
pubmed-meshheading:17559729-Double-Blind Method,
pubmed-meshheading:17559729-Female,
pubmed-meshheading:17559729-Humans,
pubmed-meshheading:17559729-Male,
pubmed-meshheading:17559729-Middle Aged,
pubmed-meshheading:17559729-Placebos,
pubmed-meshheading:17559729-Remission Induction,
pubmed-meshheading:17559729-Thiophenes,
pubmed-meshheading:17559729-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
|
pubmed:affiliation |
Department of Psychiatry, University of Florida, Gainesville, FL, USA.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|